MedTrace Logo

Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage

NCT01096589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2024-10-02

Study results available
· View outcomes & findings →

Summary

Objectives. The primary objective of the study is to assess volume reduction in the treatment of lymphoedematous legs and arms with compression bandaging.

Secondary objectives:

* Assessment of safety
* Quality of life
* Health economic parameters
* Slippage
* Subbandage pressure

Conditions

  • Lymphedema

Interventions

DEVICE

3M Coban 2 (Compression System)

Nonwoven cohesive backing and foam.

DEVICE

3M Coban 2 (Compression System)

Nonwoven cohesive backing and foam.

DEVICE

3M Coban 2 (Compression System)

Nonwoven cohesive backing and foam.

DEVICE

Comprilan

Commercial short-stretch bandage (Comprilan; BSN Medical Ltd, Hull, U.K).

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Christine Moffatt, Prof. · Faculty of Medicine, Division of Nursing and Healthcare, Universtity of Glasgow, G12 8LW

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01096589 on ClinicalTrials.gov